Effects of tiaprofenic acid on urinary pyridinium crosslinks in adjuvant arthritic rats: Comparison with doxycycline

Inflammation Research

Volumn 46, Issue 7, 1997, Pages 246-252

  Weithmann, K U ^a   Schlotte, V ^a   Jeske, V ^a   Seiffge, D ^a   Laber, A ^a   Haase, B ^a   Schleyerbach, R ^a  

^a SANOFI   (France)

Author keywords

Adjuvant arthritis; Doxycycline; Human matrix metalloproteinase; Pyridinium crosslinks; Tiaprofenic acid

Indexed keywords

CYTOKINE; DEOXYPYRIDINOLINE; DOXYCYCLINE; FREUND ADJUVANT; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; PYRIDINIUM DERIVATIVE; TIAPROFENIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG INFORMATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MONONUCLEAR CELL; NONHUMAN; ORAL DRUG ADMINISTRATION; PAW EDEMA; RAT; URINARY EXCRETION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-LINKING REAGENTS; CYTOKINES; DISEASE MODELS, ANIMAL; DOXYCYCLINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FREUND'S ADJUVANT; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; METALLOENDOPEPTIDASES; PROPIONIC ACIDS; PYRIDINIUM COMPOUNDS; RATS; RATS, WISTAR;

EID: 0030812035     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050182     Document Type: Article

References (37)

1. Ryan ME, Greenwald RA, Golub LM. Potential of tetracyclines to modify cartilage breakdown in osteoarthritis. Curr Opin Rheum 1996;8:238-47.
2. Krane SM, Conca W, Stephenson ML, Amento EP, Goldring MB. Mechanisms of matrix degradation in rheumatoid arthritis. Ann NY Acad Sci 1990;580:340-54.
3. Greenwald RA. Monitoring collagen degradation in patients with arthritis. Arthritis Rheum 1996;39:1455-65.
4. Eyre DR, Kooh TJ, Van Ness KP. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Analyt Biochem 1984;137:380-8.
5. James IT, Perret D, Thompson PW. Rapid assay for hard tissue collagen cross-links using isocratic ion-pair reversed-phase liquid chromatography. J Chromat 1990;525:43-57.
6. Woessner J Jr. The family of matrix metalloproteinases. Ann NY Acad Sci 1994;732:11-21.
7. Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe-Seyler 1995;376:345-55.
8. Bartlett RR, Schleyerbach R, Weithmann KU, Thorwart W. Pharmacological profile of HWA-131, a novel antiinflammatory agent with immunomodulating properties. Agents Actions 1990; 29:71-3.
9. Plosker GL, Wagstaff AJ, Brandt KD. Calin A, Daymond TJ, Ishioka T, et al. Tiaprofenic acid. A reappraisal of its pharmacological properties and use in the management of rheumatic diseases. Drugs 1995;50:1050-75.
10. Greenwald R. Treatment of destructive arthritic disorders with MMP inhibitors. Potential role of tetracyclines. Ann NY Acad Sci 1994;732:181-98.
11. Ye QZ, Johnson LI, Hupe DJ, Baragi V. Purification and characterization of the human stromelysin catalytic domain expressed in Escherichia. Biochem 1992;31:11231-5.
12. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, et al. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzyme properties. Eur J Biochem 1990;194:721-30.
13. Morodomi T, Ogata Y, Sasaguri Y, Morimatsu M, Nagase H. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. Biochem J 1992;285:603-11.
14. Knight CG, Willenbrock F, Murphy G. A novel coumarin- labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett 1992;296:263-6.
15. Tordjman C, Lhumeau A, Pastoureau P, Meunier F, Serkiz B, Volland JP, et al. Evaluation and comparison of urinary pyridinium crosslinks in two rat models of bone loss-ovariectomy and adjuvant polyarthritis-using a new automated HPLC method. Bone Mineral 1994;26:155-67.
16. Meyer-Carrive I, Graham GG, Ghosh P. Pharmacokinetics of tiaprofenic acid in normal rabbits and rabbits subjected to joint immobilisation. Agents Actions 1993;39:59-68.
17. Jaffe M. Über den Niederschlag, welchen Picrinsäure in Harn erzeugt, und über eine neue Reaktion des Kreatinins. Z Physiol Chem 1886;10:391-9.
18. Bøyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968;97:77-89.
19. Ganu V, Doughty J, Spirito S, Goldberg R. Elevation of urinary pyridinoline in adjuvant arthritic rats and its inhibition by doxycycline. Ann NY Acad Sci 1994;732:416-8.
20. Holland DR, Hausrath AC, Juers D, Matthews BW. Structural analysis of zinc substitutions in the active site of thermolysin. Protein Science 1995;4:1955-65.
21. Palmowski M, Brandt K. In vivo effect of aspirin on canine osteoarthritic cartilage. Arthritis Rheum 1983;26:994-1001.
22. Huskisson EC, Berry H, Gishen P, Jubb RW, Whitehead J. Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. J Rheumatol 1995;22:1941-6.
23. Meyer-Carrive I, Ghosh P. Effects of tiaprofenic acid on cartilage proteoglycans in the rabbit joint immobilisation model. Ann Rheum Dis 1992;51:448-55.
24. Karppinen J, Inkinen RI, Kaapa E, Lammi MJ, Tammi MI, Holm S, et al. Effects of tiaprofenic acid and indomethacin on proteoglycans in the dgenerating porcine intervertebral disc. SPINE 1995;20:1170-7.
25. Srinivas GR, Chicester CO, Barrach HJ, Matoney AL. Effects of certain antiarthritic agents on the synthesis of type II collagen and glycosaminoglycans in rat chondrosarcoma cultures. Agents Actions 1994;41:193-9.
26. Golub LM, Lee HM, Lehrer G, Nemirott A, McNamara TF, Kaplan R, et al. Minocycline reduces gingival collagenolytic activity during diabetes: preliminary observations and proposed new mechanism of action. J Periodont Res 1983;18:516-26.
27. Yu L, Smith G, Brandt K, O'Connor B, Myers S. Therapeutic administration of doxycycline slows the progression of cartilage destruction in canine osteoarthritis. Trans Orthop Res Soc 1993;18:724-5.
28. Greenwald RA, Moak SA, Golub LM. Low dose doxycycline inhibits pyridinoline excretion in selected patients with rheumatoid arthritis. Ann NY Acad Sci 1994;732:419-21.
29. Pelletier JP, Cloutier JM, Martel-Pelletier J. In vitro effects of NSAIDs and corticosteroids on the synthesis and secretion of interleukin 1 by human osteoarthritic synovial membranes. Agents Actions 1993;39 suppl 7:181-93.
30. Shapira L, Soskolne WA, Houri Y, Barak V, Halabi A, Stabholz A. Protection against endotoxic shock and lipopolysaccharide induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. Infect Immunity 1996;64:825-8.
31. Sorsa T, Ding Y, Salo T, Lauhio A, Teronen O, Ingman T, et al. Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. Ann NY Acad Sci 1994;732:112-31.
32. Smith GN, Brandt KD, Hasty KA. Procollagenase is reduced to inactive fragments upon activation in the presence of doxycycline. Ann NY Acad Sci 1994;732:436-8.
33. Greenwald RA, Golub L, Lavaites B, Ramamurthy NS, Gruber B, Laskin RS, et al. Minocycline inhibits rheumatoid synovial collagenase in vivo and in vitro. J Rheumatol 1987;14:23-8.
34. Vignon E, Mathieu P, Broquet P, Louisot P, Richard M. Cartilage degradative enzymes in human osteoarthritis: effects of a nonsteroidal antiinflammatory drug administered orally. Semin Arthritis Rheum 1990; 19(Suppl 1): 26-9.
35. Stovickova J, Skrivankova B, Vilimova Z, Trnavsky K. Influence of flobufen, the new non-steroidal antirheumatic drug, on gelatinolytic and caseinolytic activity of rabbit chondrocytes. Rheumatologia 1994;8:151-62.
36. Steinmeyer J, Daufeldt S, Kalbhen DA. Pharmacologic influence on the activity of stromelysin from bovine articular cartilage. Ann NY Acad Sci 1994;732:482-3.
37. Paemen L, Martens E, Norga K, Masure S, Roets E, Hoogmartens J, et al. The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors. Biochem Pharmac 1996; 52:105-11.